Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, No. 87 Dingjiaqiao, Nanjing, Jiangsu 210009, China.
Pancreatic Research Institute, Southeast University, China.
J Diabetes Res. 2020 Mar 23;2020:9787839. doi: 10.1155/2020/9787839. eCollection 2020.
Pancreatic stone protein/regenerating protein I (PSP/REG I) is a secretory protein mainly detected in the pancreas. Recent studies revealed increased serum PSP/REG I) is a secretory protein mainly detected in the pancreas. Recent studies revealed increased serum PSP/REG I) is a secretory protein mainly detected in the pancreas. Recent studies revealed increased serum PSP/REG I.
This cross-sectional study was conducted at Zhongda Hospital, affiliated with Southeast University in China. Serum PSP/REG I) is a secretory protein mainly detected in the pancreas. Recent studies revealed increased serum PSP/REG I) is a secretory protein mainly detected in the pancreas. Recent studies revealed increased serum PSP/REG I.
Serum PSP/REG I) is a secretory protein mainly detected in the pancreas. Recent studies revealed increased serum PSP/REG I < 0.05). The level of PSP/REG I) is a secretory protein mainly detected in the pancreas. Recent studies revealed increased serum PSP/REG I) is a secretory protein mainly detected in the pancreas. Recent studies revealed increased serum PSP/REG I.
Serum PSP/REG I level is significantly upregulated in T2DM patients and reflects renal function in both T2DM and nondiabetic control groups. The relationship between PSP/REG I and eGFR suggested that PSP/REG I might be a potential indicator of renal dysfunction.) is a secretory protein mainly detected in the pancreas. Recent studies revealed increased serum PSP/REG I) is a secretory protein mainly detected in the pancreas. Recent studies revealed increased serum PSP/REG I) is a secretory protein mainly detected in the pancreas. Recent studies revealed increased serum PSP/REG I.
胰腺分泌蛋白/再生蛋白 I(PSP/REG I)是一种主要在胰腺中检测到的分泌蛋白。最近的研究表明,血清 PSP/REG I 水平在 2 型糖尿病(T2DM)患者中显著上调,并反映了 T2DM 和非糖尿病对照组的肾功能。PSP/REG I 与 eGFR 的关系表明,PSP/REG I 可能是肾功能障碍的潜在指标。
本横断面研究在中国东南大学附属中大医院进行。
与非糖尿病对照组相比,T2DM 患者的血清 PSP/REG I 水平显著升高(P<0.05)。在 T2DM 和非糖尿病对照组中,PSP/REG I 水平与 eGFR 呈负相关(r=-0.324,P<0.001;r=-0.315,P<0.001)。
血清 PSP/REG I 水平在 T2DM 患者中显著上调,并反映了 T2DM 和非糖尿病对照组的肾功能。PSP/REG I 与 eGFR 的关系表明,PSP/REG I 可能是肾功能障碍的潜在指标。